SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Neurology (movement disorders) Consultation — Muhammad Ali

PatientMuhammad Ali
Date of birth1972-01-17
IdentifiersMRN HR-BX001-SYN; SSN (made up) 000-01-7724
Document date2026-03-10
AuthorKwame Asante, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Young-onset Parkinson's disease, diagnosed twelve years ago at 42, in a 54-year-old man whose slowness of movement now limits daily tasks on a modest levodopa dose. Please review the diagnosis, advise on the levodopa dose or another agent, and plan rehabilitation for his soft speech and gait. [S]

Urgency: Routine, within four weeks, on the same day as his four-week primary care check. [S]

Questions for the consultant:

History of Present Illness

Mr. Ali, a 54-year-old man with parkinsonism diagnosed twelve years ago at 42, is seen at the request of Dr. Moreau. Slowness of movement is his main limitation: buttoning, handwriting, and rising from low chairs take longer, most of all in the late morning and late afternoon. He has a mild right-hand tremor at rest. His voice is soft, and people have trouble hearing him in crowds. He takes carbidopa-levodopa 25/100 mg one tablet three times a day, often with meals, and notices no wearing-off before doses, no involuntary movements, no freezing, and no lightheadedness on standing. He has had no falls, hallucinations, dream enactment, or new urges to gamble, shop, or eat. He boxed professionally until three years before the diagnosis. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Carbidopa-levodopa 25/100 mg oral tablet, one tablet by mouth three times dailyOne tablet by mouth three times daily, at about 7 a.m., noon, and 5 p.m.Oral route2014-10-01 to 2026-03-10completedS
Carbidopa-levodopa 25/100 mg oral tablet, one and a half tablets by mouth three times daily, 30 minutes before mealsOne and a half tablets (levodopa 150 mg) by mouth three times daily, 30 minutes before mealsOral route2026-03-10activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Parkinson's disease, young onset (diagnosed at 42), Hoehn and Yahr stage 2.5, without dyskinesia or motor fluctuationsactiveconfirmed G20.A1S — Synthetic modern coding of the publicly disclosed diagnosis; the stage and the absence of motor complications are synthetic.
Hypokinetic dysarthria with soft speech due to Parkinson's diseaseactiveconfirmed R47.1S — Synthetic modern coding of the publicly reported speech difficulty; the severity is synthetic.

Physical Exam

Vital signs recorded on 2026-03-10; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralAlert, humorous, and engaged; reduced facial expression and blinking
Mental statusFully oriented; fluent, coherent speech, soft and monotone
Eye movementsFull range, including vertical gaze; slightly slowed saccades; no square-wave jerks
MotorMDS-UPDRS Part III 30 in the on state, about two hours after a dose. Bradykinesia with decrement on finger and foot tapping, worse on the right; rigidity in all limbs, worse on the right; mild right-hand rest tremor; no dyskinesia, dystonia, or myoclonus
Coordination and reflexesNo cerebellar signs; reflexes symmetric; plantar responses flexor
GaitShort steps with reduced arm swing; no freezing; recovers after three steps on the pull test; Hoehn and Yahr stage 2.5
Orthostatic check128/80 mmHg supine and 122/78 mmHg at 3 minutes standing, without symptoms

Assessment

Data reviewed: Dr. Moreau's first-visit assessment four weeks ago: MDS-UPDRS Part III 30, Hoehn and Yahr stage 2.5, Timed Up and Go 13 seconds, pull test, supine and standing blood pressure, MoCA 27, PHQ-9 3, EAT-10 2, sleep and impulse-control screens; blood count, chemistry, vitamin B12, and TSH from the same visit; and today's supine and standing blood pressure. [S]

Plan of Treatment